NaCl), LPS (0.1 mg/kg), or PAM (1 mg/kg). Core temperature and weight gain were monitored. Brain cytokine expression (IL-6, IL-1β, TNF-α, and IL-10, via PCR), apoptosis (cleaved caspase 3, via Western blots), and microglial activation (Iba1, via immunohistochemistry) were examined. Results: LPS induced an immediate drop in core temperature followed by poor weight gain, none of which were seen after PAM. Furthermore, LPS induced brain apoptosis, while PAM did not. The magnitude and temporal profile of brain cytokine expression differed between LPS-and PAM-injected animals. Conclusion: These findings reveal sepsis-like conditions and neuroinflammation specific to the inflammatory stimulus (gram-positive vs. gram-negative) in the neonatal rat. They emphasise the importance of pre-clinical models being pathogen dependent, and should always be carefully tailored to their clinical scenario.
neonatal brain to hypoxic-ischaemic (HI) insults and is considered a risk factor for neurodevelopmental sequelae [2] . Although therapeutic hypothermia (HT) is an effective neuroprotective strategy after HI injury, 40-50% of patients still have poor developmental outcome, including death [3] . As clinical trials of HT in parts of the world where infection rates are higher failed to show benefit, clinicians and researchers are questioning whether comorbidities such as perinatal infection could negate the neuroprotective effect of HT [2, 4] . Exposure of the postnatal day 7 (P7) rat to lipopolysaccharide (LPS) prior to a mild HI insult significantly increased brain injury and abolished the neuroprotective effects of HT [5] , supporting that hypothesis. However, LPS represents only gramnegative bacterial infections. Gram-negative and grampositive species activate the immune system through different pathogen recognition receptors and subsequent immunological pathways [6] . While LPS binds primarily to toll-like receptor (TLR)-4, gram-positive bacterial cell wall molecules adhere to TLR-2 on the host immune cells to activate the inflammatory cascade, and have been shown to be TLR-4 independent ( Fig. 1 ) [6] . Pre-sensitising with the synthetic TLR-2 agonist PAM 3 CSK 4 (PAM) in the same neonatal rat model of HI brain injury simulated gram-positive infection and induced brain injury of the same severity, but the neuroprotective effect of HT was preserved [7] .
Although in most cases of early-onset sepsis the causative agent remains unidentified, a recent populationbased study showed that 91% of culture-positive sepsis cases among term-born babies were caused by gram-positive bacterial species [8] .
Using neonatal rat pups without inducing HI brain injury, we investigated differences in inflammatory response to triggers of TLR-2 and TLR-4, respectively, with focus on temporal core temperature changes, development of intracerebral apoptotic cell death and neuro-inflammatory markers, and weight gain representing wellbeing in the neonate.
Materials and Methods

Animals and Injections
All experiments were approved by the University of Oslo's Animal Ethics Research Committee. Experiments were performed on P7 Wistar rats (Charles River Laboratories, Sulzfeld, Germany) of both genders. All pups were kept in an animal facility with a 12: 12-h dark:light cycle at an environmental temperature of 21 ° C with food and water ad libitum. The animals were always randomised across litter, sex, and weight before the experiments commenced.
We used LPS from Escherichia coli 055:B5 (Sigma; 0.1 mg/kg) and the synthetically manufactured TLR-2/1 agonist PAM (Vaccigrade, Sigma-Aldrich; 1 mg/kg). Vehicle (Veh) for dilutions was sterile 0.9% NaCl. The LPS dose is one that previously sensitised the neonatal brain to HI brain injury [5] . We based the PAM dose on previous publications [9] , as well as our own dose-response experiments from developing the model of PAM-sensitised HI brain injury [7] . The PAM model was developed to explore the neuroprotective effect of hypothermia after PAM-sensitised HI brain injury. We therefore aimed for a dose which induced the same level of infection-sensitised injury as that in our LPS-sensitised model, where hypothermic neuroprotection was negated [5] . Control groups received a single dose of Veh. All injections were given intraperitoneally in a volume of 10µL/g body weight, at room temperature (21 ° C).
Core Temperature Recordings P7 rats (n = 29) received a Veh (n = 9), LPS (n = 10), or PAM (n = 10) injection. Core temperature was monitored using a rectal probe (IT-21; Physitemp Instruments, Clifton, NJ, USA) at 9 selected time points after injection (0, 1, 2, 4, 6, 8, 10, 12, and 24 h). All groups were handled similarly throughout the experiment, which was performed in a temperature-controlled room (21 ± 0.5 ° C). To record the individual nesting temperature at a given time, 1 pup was removed from the dam at a time for temperature recording before being returned to the dam.
Weight Gain Analysis
In a separate study, P7 pups (n = 36) received injections as described (Veh, LPS, or PAM), and were returned to their dams. At P14 all pups were weighed separately. Weight gain was calculated as percentage gain from P7 to P14.
Brain Apoptosis
The apoptotic protein marker cleaved caspase 3 (cCas3) was examined in brain tissue at 24 and 48 h after injections using Western blot (WB) technique as previously described [10] . Three groups were examined at 24 h (n = 36): Veh, LPS, and PAM. For the 48-h follow-up only LPS and PAM data were available (n = 6 per group). Image Lab software, version 5.2.1 (Bio-Rad, Hercules, CA, USA) was used for optical density measurements of protein signals on scans in ChemiDoc TM Touch Imaging Systems (Bio-Rad).
Brain Cytokine Expression
Using qRT-PCR, we studied the time course of pro-inflammatory (IL-6, IL-1β, TNF-α) and anti-inflammatory (IL-10) cytokines expressed in brain tissue after systemic LPS injection (n = 50) over a 48-h period. Subsequently, the same cytokines were examined in brain tissue after systemic injections of PAM (n = 50) or Veh (n = 50). Nine post-injection time points were selected for analysis in LPS-and PAM-injected animals (0, 2, 4, 6, 12, 18, 24, 36, and 48 h). Four time points (0, 4, 8, and 24 h) were selected in the Veh group. Brains were harvested at the selected time points and snap frozen in liquid nitrogen before storage at -80 ° C.
Using the RNeasy Mini Kit (Qiagen), total RNA was extracted and the concentration measured with a NanoDrop spectrophotometer. cDNA was synthesised from 1 µg RNA using the qScript TM cDNA Synthesis Kit (Quanta Biosciences). qRT-PCR was performed with the ABI7900 sequence detection system (Applied Biosystems, Foster City, CA, USA) in a 10-µL total volume, using 
Microglial Activation
Ionised calcium-binding adaptor molecule 1 (Iba1) was examined by WB technique at 48 h after injections, as described previously (n = 18) [10] .
Iba1 immunoreactivity was analysed in animals with 7 days' survival (n = 30), as described previously [10] . Virtual slides were exported as high-resolution TIFF images for further analysis with ImageJ software, version 1.46r (National Institutes of Health, Bethesda, MD, USA), detecting Iba1 immunoreactivity. The summed intensity detected was analysed by 2 individual observers blinded to the treatment groups. Inter-rater reliability was crosschecked using Pearson correlation coefficient analysis. An average of the 2 methods was taken for comparison across treatment groups. Microglial activation was expressed as Iba1 detected relative to hemispheric area in the same brain.
Statistical Data Analyses
Statistical analyses were performed using GraphPad Prism, version 6 (GraphPad Software Inc., La Jolla, CA, USA). Temperature measurements are presented as mean ± SEM. For weight gain as well as cytokine and WB analysis, descriptive data are presented as median with 95% confidence intervals (CI), as these data were not normally distributed. Multi-group comparisons were done using the Kruskal-Wallis test, and Mann-Whitney-Wilcoxon rank sum tests were used for comparing 2 groups to get exact 2-tailed p values. Due to the variable spread in cCas3 and cytokine expression data, the Kolmogorov-Smirnov test was used for group-togroup comparisons. A p value <0.05 (2-sided) was considered statistically significant.
Results
Core Temperature Changes
At 2 h after injection of LPS, mean core temperatures had already dropped by 4.3 ° C (2.7-6.4), a significantly greater temperature reduction than that in Veh-and PAM-injected animals, which dropped by 2.5 ° C (0.2-3.0) (p < 0.01) and 2.1 ° C (1.1-4.8) (p < 0.01), respectively. It took 8 h before core temperatures in the LPS-injected group increased to the same level as those in the PAM and Veh groups (Fig. 2) .
Differences in Weight Gain
The Veh-and PAM-injected groups had a similar median weight gain 1 week after injections: 138% (130.5-145.5) and 145.6% (134.1-137.1), respectively. The LPSinjected pups, however, had significantly poorer weight gain at a median of 115.2% (91.5-138.9) compared to the Veh group (p = 0.02) and the PAM group (p < 0.01).
Intracerebral Apoptosis cCas3 was significantly increased in the brains of LPSinjected animals after 24 h compared to the Veh and PAM groups (both p < 0.005). cCas3 continued to increase for the next 24 h in LPS animals. After PAM injection there was no elevation of cCas3 at 24 h, similar to the result after Veh injection, nor did it elevate over the next day (Fig. 3b) .
Cytokine Expression in Brain Tissue
The temporal changes in cerebral cytokine expression (IL-6, IL-1β, TNF-α, IL-10) after peripheral injections of PAM and LPS are shown in Table 1 . After injection of Veh, none of the 4 cytokines were significantly elevated at any time (Fig. 4a) .
Up-regulation of cerebral cytokines was found to be specific to the stimulus (Fig. 4b) . After LPS, IL-6 expression increased rapidly within 2 h, and after a second peak at 12 h returned to baseline levels. After PAM injection there was a later (6 h) significant change in the IL-6 level. TNF-α expression was also already significantly increased at 2 h after LPS injection. The TNF-α peak induced by PAM injection was seen later, at 6-12 h. IL-1β expression was strongly up-regulated in both groups, but while the level of this pro-inflammatory cytokine also immediately rose in the LPS group, the response was somewhat delayed in the PAM group. The pattern was different for IL-10. A small but significant change was seen 6 h after LPS injection, while in PAM-injected animals the IL-10 response was immediate and sustained.
Microglial Activation in Response to Systemic
Injections WB from snap-frozen brain tissue collected 48 h after injections showed no differences between LPS (1.5; 1.2-1.9) and PAM animals (1.4; 1.3-1.6). Iba1 was, however, significantly higher in animals that had received LPS or PAM compared to Veh (1.2; 1.0-1.4) (p = 0.04 for both comparisons) (Fig. 5a) .
Immunofluorescence-labelled Iba1-specific antibodies revealed microglia throughout the brains of pups from all groups at P14. Again there was no difference between LPS-injected (87.8; 40.4-136) and PAM-injected (71.5; 56.4-108.3) animals. The median Iba1 labelling detected was higher in pups that had received LPS or PAM than in Veh animals (33.1; 24.6-138.6), although not statistically significant (p = 0.21 and p = 0.28, respectively). By appearance, there was no obvious difference in the number of microglia across the 3 groups; however, microglia in the activated state were found in LPS-and PAM-injected animals, but not in the Veh group (Fig. 5b-d) .
Discussion
In this study of juvenile rats with brain maturation equal to near-term humans, we found pathogen-dependent inflammatory responses after either LPS (a gramnegative stimulus) or PAM (a gram-positive stimulus) administration.
When term newborn infants need HT after perinatal asphyxia, cooling starts within a few hours. Whether an infection negates the neuroprotective effect of HT is a major question. To a similar degree, pre-sensitisation with LPS and PAM increased injury at normothermic recovery [7, 11] . With experimental HI followed by HT, LPS negated neuroprotection [5] , unlike PAM, where HT had a significant effect [7] . With current diagnostic methods, the causative pathogen in the case of a concomitant infection cannot be revealed in time to impact the decision of whether to cool or not. However, if most infections in term-born neonates in the industrialised part of the world are caused by gram-positive pathogens [8, 12] , the decision to cool should not be delayed by these diagnostic challenges.
To further explore differences between 2 clinically relevant immune response pathways, the current study addresses the effect of LPS and PAM on physiology and neuropathology in juvenile animals without an HI injury.
Within 2 h after LPS administration, the core temperature dropped significantly in these P7 rat pups, unlike that in the Veh-or PAM-injected animals. With the exception of a brief temperature reduction following injection of a room-tempered solution (21 ° C), the temperature development of Veh or PAM animals remained steady. Rodents have previously been shown to develop hypothermia in response to a significant systemic infection [13] . However, in most studies on rodent sepsis the stimulants have been gram-negative bacteria or LPS injection. In human sepsis, loss of core temperature ("cold sepsis") is thought to indicate a more severe generalised disease state with higher mortality [14] . When a spontaneous drop in core temperature is a result of HI brain injury, it has been shown to be a strong predictor of poor outcome [15] . It is reasonable to interpret the temperature changes seen after LPS here as a sign of a more severe The Kruskal-Wallis test (KW) was used for multi-group comparisons. Change in expression of each specific cytokine was compared against the same cytokine at 0 h (n = 5) using the Kolmogorov-Smirnov test. * p < 0.05 was considered significant. generalised disease state than that seen in the littermates that received PAM.
Microglial activation was seen both at 48 h and at 7 days after PAM and LPS injections, and to a similar degree. This supports the idea that inflammatory activation in blood leads to activation of the monocyte line in the CNS [16] . Some, or even a majority, of the Iba1-positive cells seen in the brain after systemic inflammation are peripheral monocytes [17] . TNF-α has been shown to play a major role in the recruitment of these cells from blood to brain [18] . IL-6 is a key factor stimulating microglial activation and proliferation [19] . Both LPS and PAM induced significant elevations of TNF-α and IL-6 well within the time point where we analysed microglial activation, and can therefore explain the similarity of Iba1 density.
The activation of monocytes/microglia and their release of pro-inflammatory molecules induce cellular death [20] . Kim et al. [20] attributed LPS-induced neurotoxicity and apoptosis to microglial density. Interestingly however, apoptosis was induced in the LPS-injected animals, but not in the PAM-injected ones (Fig. 3) . This suggests that the mechanism of inflammatory-induced apoptosis is not restricted simply to microglial/monocytal activation, but might be modified by microglial phenotype or other immunological events, especially in gram-positive inflammation.
The LPS-induced apoptosis demonstrated above is in line with previous studies [21] . The authors concluded that the LPS-induced changes could be interpreted as downstream effects of sepsis. The profound differences 218 between these 2 main pathways of inflammatory activation have clinical importance in the context of the injurious impact of systemic infection on the immature brain -in sensitisation of the term neonatal brain to HI injury, as well as in white matter injury induced by systemic inflammation in the premature infant [22] . Our findings suggest that the mechanisms behind these phenomena are complex and not only the inflammation per se. The differing temporal patterns of various pro-and anti-inflammatory cytokines might play an important role. IL-6 and TNF-α play important roles in the thermal response to inflammation [23] and increased sickness behaviour [24] . Our findings of intracerebral IL-6 and TNF-α surges already 2 h after LPS injection, which coincide with a drop in core temperature, support the thermoregulatory role of these cytokines and explains a reduction in food intake. The increased IL-6 and TNF-α levels in the brains of PAM-injected pups only reach statistical significance after a delay of 6-12 h. Here, however, they peak without a concomitant change in core temperature, and with satisfactory weight gain. In contrast to LPS animals, the increased IL-6 and TNF-α in PAM animals was accompanied by an elevated IL-10 level.
IL-1β expression was significantly increased after both LPS and PAM injections. IL-10 was briefly elevated after LPS, while it was significantly increased at 2 h and remained elevated until 18 h after PAM. Several studies suggest a protective role of IL-10 through modulation of ongoing inflammation. IL-10 was shown to reduce excitotoxic brain injury triggered by IL-1β in neonatal mice [25] . A genetic polymorphism that results in increased production of IL-10 has been associated with decreased white matter injury and reduced risk of cerebral palsy in studies on very premature infants [26] , also supporting the neuroprotective role of IL-10. Due to the limitation of crushed tissue, we have not studied the intracerebral responses regionally. Specifically, LPS induced apoptosis in cultured neurons and microglia, but not in astrocytes [27] , and apoptosis has been shown to be dependent on cell type density for various brain regions [20] . Exploring regions known to be particularly vulnerable to HI like the hippocampus and cortex could also help to elucidate inflammatory sensitisation and its relation to temperature changes. Another significant limitation to this study is the challenge of interpretation. Current knowledge on specific cytokines and their action in pathological situations are uncertain. Additionally, studies on the translation of immune responses from rodents to humans are scarce [28] .
Researchers have approached a sepsis-like scenario by using LPS in various animal models spanning a wide range of clinical fields [29, 30] . LPS is relatively inexpensive and has been thoroughly investigated as a potent inflammatory trigger. However, the limitation that LPS exclusively represents gram-negative infections has not often been addressed. Our findings raise the question of how other inflammatory triggers, both acute and chronic, including viral and parasitic infections, may affect outcome after HI. Both hypoxia and LPS prior to the HI insult have displayed pre-conditioning activities, and the timing is determinant of the outcome [31, 32] . The physiological and neuroinflammatory responses in various settings of inflammation are under constant investigation. How they as co-morbidities to HI encephalopathy might modify hypothermic neuroprotection is still unknown.
We can conclude that the temporal upregulation of these mediators of cellular death and inflammation are different for analogues of a gram-positive and gram-negative systemic infection, with different downstream thermoregulatory effects, in the neonatal rat. Therefore, it is important to acknowledge that using LPS in pre-clinical models of inflammation may not always reflect the clinical scenario appropriately.
